Àü³²´ëº´¿ø ±â½ÂÁ¤¡¤ÃÖÇö¿ì ±³¼öÆÀ ±¹Á¦Çмú´ëȸ¼ ¡®¿ì¼öÇмú»ó¡¯ ¼ö»ó ¿Àº¹ ±âÀÚ |
2023³â 08¿ù 16ÀÏ(¼ö) 20:20 |
|
16ÀÏ Àü³²´ëÇб³º´¿ø¿¡ µû¸£¸é Áø´Ü°Ë»çÀÇÇаú ±â½ÂÁ¤¡¤ÃÖÇö¿ì ±³¼öÆÀÀÌ Áö³´Þ 23ÀϺÎÅÍ 5ÀÏ°£ ¹Ì±¹ ¾Ö³ÊÇÏÀÓ¿¡¼ ¿¸° ¡®2023 American Association of Clinical Chemistry (AACC) Annual Scientific Meeting¡¯¿¡¼ ÀÓ»óÁø´Ü¸é¿ªºÐ°ú ¿ì¼öÇмú»ó(Abstract Award in Clinical and Diagnostic Immunology)À» ¼ö»óÇß´Ù.
¿ÃÇØ·Î 74ȸ¸¦ ¸ÂÀº AACC Çмú´ëȸ´Â ¹Ì±¹ÀÓ»óÈÇÐȸ°¡ ÁÖ°üÇÏ´Â Àü ¼¼°è Áø´Ü°Ë»çÀÇÇÐ Àü¹®ÀÇ¿Í °ü·Ã¾÷ü °ü°èÀÚµéÀÌ Âü¿©ÇÏ´Â ¼¼°è ÃÖ´ë ±Ô¸ðÀÇ Áø´Ü°Ë»ç ºÐ¾ß Çмú´ëȸÀÌÀÚ ¹Ú¶÷ȸ´Ù.
À̹ø Çмú´ëȸ¿¡´Â ÃÑ 780¿©°ÇÀÇ ³í¹®ÃÊ·ÏÀÌ Á¦ÃâµÆÀ¸¸ç ÀÓ»óÁø´Ü¸é¿ªºÐ°ú·Î Á¦ÃâµÈ 140¿©°Ç Áß 3°ÇÀÌ ¿ì¼öÇмú»óÀ¸·Î ¼±Á¤, ¿¬±¸³»¿ëÀ» ¹ßÇ¥Çß´Ù.
±â½ÂÁ¤¡¤ÃÖÇö¿ì ±³¼öÆÀÀÌ ¹ßÇ¥ÇÑ ¿¬±¸´Â ¡®Ç× DFS-70 Ç×ü °ËÃâÀ» µ¿¹ÝÇÑ AC-2 ÆÐÅÏ º¸°íÀÇ ÀÓ»óÀû À¯¿ë¼º(The Clinical Utility of Reporting AC-2 Pattern With Anti-DFS70 Antibody)¡¯À¸·Î ÀÚ°¡¸é¿ªÁúȯÀÇ ¼±º°°Ë»ç·Î ½ÃÇàµÇ´Â Ç×ÇÙÇ×ü(antinuclear antibody¡¤ANA), °£Á¢¸é¿ªÇü±¤Ç×ü°Ë»ç¹ý(indirect immunofluorescence assay¡¤IFA)¿¡¼ °üÂûµÇ´Â dense fine speckled(DFS) ÆÐÅÏ°ú °ü·Ã Ç×üÀÎ anti-DFS70 Ç×ü¿¡ ´ëÇÑ ÀÓ»óÀû À¯¿ë¼ºÀ» ºÐ¼®ÇÑ º¸°í´Ù./¿Àº¹ ±âÀÚ
¿Àº¹ ±âÀÚ